PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.\', \'Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Wuhan, China.\', \'Convalife (Shanghai) Company Ltd, Shanghai, China.\', \'Department of Oncology, Fifth Hospital of Wuhan, Wuhan, China.\', \'Department of Infection, Seventh Hospital of Wuhan, Wuhan, China.\', \'Department of Oncology, Han Kou Hospital of Wuhan, Wuhan, China.\', \'Center for Evidence-based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.\', \'Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.\', \'Division of Radiation Oncology, National Cancer Center Singapore, Singapore, Singapore.\', \'Division of Medical Sciences, National Cancer Center Singapore, Singapore, Singapore.\', \'Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cncr.33042
?:doi
?:hasPublicationType
?:journal
  • Cancer
is ?:pmid of
?:pmid
?:pmid
  • 32573776
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.455
?:rankingScore_hIndex
  • 265
?:title
  • Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all